4/A//SEC Filing
Grinstead Eric 4/A
Accession 0001181431-12-002286
CIK 0000911326other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 6:01 PM ET
Size
5.9 KB
Accession
0001181431-12-002286
Insider Transaction Report
Form 4/AAmended
Grinstead Eric
SVP, Commercial Operations
Transactions
- Award
Stock Option (Right to Buy)
2011-12-20+40,000→ 40,000 totalExercise: $23.00Exp: 2021-12-19→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]The Option is subject to the issuer's shareholders approving an amendment to the 2005 Stock Option plan.
- [F2]This amendment is filed solely to correct a clerical error in the initial filing. In this regard the number of options acquired was incorrectly included in the disposition column rather than the acquisition column.
- [F3]25% of the total number of Shares subject to the Option vest and become exercisable on 12/20/2012 and 1/36 of the remainder of the Shares subject to the Option shall vest and become exercisable monthly thereafter.
Documents
Issuer
SYNAGEVA BIOPHARMA CORP
CIK 0000911326
Entity typeother
Related Parties
1- filerCIK 0001532221
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 6:01 PM ET
- Size
- 5.9 KB